BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14293307)

  • 1. DECREASED PATHOGENICITY FOR RABBIT SKIN OF IDU-RESISTANT VACCINIA VIRUS.
    FERRARI W; GESSA GL; LODDO B; SCHIVO ML
    Virology; 1965 May; 26():154-5. PubMed ID: 14293307
    [No Abstract]   [Full Text] [Related]  

  • 2. PLAQUE FORMATION BY VACCINIA VIRUS IN TISSUE CULTURES INHIBITED BY 5-FLUORODEOXYURIDINE.
    BAXBY D; RONDLE CJ
    J Gen Microbiol; 1965 Mar; 38():423-7. PubMed ID: 14334612
    [No Abstract]   [Full Text] [Related]  

  • 3. Susceptibility of primary and continuous cell lines to vaccinia virus.
    Konieczna M; Szalaty H; Kuczkowska B; Kańtoch M
    Arch Immunol Ther Exp (Warsz); 1966; 14(3):350-5. PubMed ID: 5919649
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and interrelationships of the variola/vaccinia subgroup of poxviruses.
    Baxby D
    Prog Med Virol; 1975; 19():215-46. PubMed ID: 164050
    [No Abstract]   [Full Text] [Related]  

  • 5. [Isolation and characterization of cowpox virus].
    Kubin G
    Wien Tierarztl Monatsschr; 1970; 57(6):227-32. PubMed ID: 5537837
    [No Abstract]   [Full Text] [Related]  

  • 6. A NEW METHOD OF CULTIVATING VACCINIA AND VARIOLA VIRUSES IN ORGAN CULTURES OF RABBIT CORNEAE.
    KANTOCH M; KUCZKOWSKA B
    Arch Immunol Ther Exp (Warsz); 1964; 12():709-23. PubMed ID: 14249831
    [No Abstract]   [Full Text] [Related]  

  • 7. [COMPARATIVE STUDY OF SOME STRAINS OF VACCINIA VIRUS. II. PATHOGENICITY FOR LABORATORY ANIMALS].
    MARENNIKOVA SS; MALTSEVA NN
    Vopr Virusol; 1964; 126():287-91. PubMed ID: 14237276
    [No Abstract]   [Full Text] [Related]  

  • 8. IMMUNOPRECIPITATING SOLUBLE VACCINIA VIRUS ANTIGENS.
    MARQUARDT J; HOLM SE; LYCKE E
    Arch Gesamte Virusforsch; 1965; 15():178-87. PubMed ID: 14269252
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the differentiation of variola and vaccinia viruses.
    Kańtoch M; Kuczkowska B
    Arch Immunol Ther Exp (Warsz); 1966; 14(3):339-49. PubMed ID: 4288301
    [No Abstract]   [Full Text] [Related]  

  • 10. VACCINIA VIRUS-HELA CELL INTERACTION. I. THE EFFECT OF IMMUNE SERUM ON THE PRODUCTION OF INFECTIVE VIRUS, COMPLEMENT-FIXING ANTIGEN, AND HEMAGGLUTININ.
    ODA M
    Virology; 1963 Aug; 20():552-8. PubMed ID: 14059822
    [No Abstract]   [Full Text] [Related]  

  • 11. CONTRIBUTION TO THE CULTIVATION IN VITRO OF VACCINIA-VIRUS FOR THE PREVENTION OF VARIOLA.
    FRENKEL HS
    Isr Med J; 1963; 22():433-41. PubMed ID: 14153477
    [No Abstract]   [Full Text] [Related]  

  • 12. INCORPORATION OF 5-IODO-2'-DEOXYURIDINE INTO THE DEOXYRIBONUCLEIC ACID OF VACCINIA VIRUS.
    PRUSOFF WH; BAKHLE YS; MCCREA JF
    Nature; 1963 Sep; 199():1310-1. PubMed ID: 14074618
    [No Abstract]   [Full Text] [Related]  

  • 13. BIOLOGICAL AND BIOCHEMICAL PROPERTIES OF THE ANALOGUE ANTIBIOTIC TUBERCIDIN.
    ACS G; REICH E; MORI M
    Proc Natl Acad Sci U S A; 1964 Aug; 52(2):493-501. PubMed ID: 14206615
    [No Abstract]   [Full Text] [Related]  

  • 14. Temperature mutants and recombinants of vaccinia virus. II. Recombination between temperature mutants.
    Fidziańska E
    Acta Virol; 1972 Jul; 16(4):298-307. PubMed ID: 4403171
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reactivation within the poxvirus group. 3. Reactivation of thermally inactivated vaccinia virus irradiated by ultraviolet rays].
    Mazur B
    Med Dosw Mikrobiol; 1969; 21(2):175-82. PubMed ID: 5348189
    [No Abstract]   [Full Text] [Related]  

  • 16. Temperature mutants and recombinants of vaccinia virus. I. Genetic characteristics of temperature mutants.
    Fidziańska E
    Acta Virol; 1972 Jul; 16(4):291-7. PubMed ID: 4403170
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on reactivation in Poxvirus group. IV. Reactivation of so-called hot mutant of heat-inactivated vaccinia virus by so-called active cold mutant in Hep-2 cell culture at 41 degrees C].
    Mazur B
    Med Dosw Mikrobiol; 1970; 22(3):257-67. PubMed ID: 5483150
    [No Abstract]   [Full Text] [Related]  

  • 18. INHIBITING ACTIVITY OF SULPHONIAZIDE AGAINST POLIOVIRUS AND VACCINIA VIRUS.
    LODDO B; GESSA GL; FERRARI W
    Lancet; 1964 Apr; 1(7337):796-7. PubMed ID: 14108008
    [No Abstract]   [Full Text] [Related]  

  • 19. EFFECT OF IMMUNIZATION ON TISSUE SUSCEPTIBILITY TO VACCINIA VIRUS IN VITRO.
    STEINBERGER A; RIGHTS FL
    Virology; 1963 Nov; 21():402-10. PubMed ID: 14081365
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemistry of vaccinia-infected mouse fibroblasts (strain L-M). III. Radioautographic and biochemical studies of thymidine-H3 uptake into DNA of L-M cells and rabbit cells in primary culture.
    KIT S; DUBBS DR; HSU TC
    Virology; 1963 Jan; 19():13-22. PubMed ID: 14033126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.